Catalent Supports U.S. Launch of Phathom Pharmaceuticals ’ New Products...
Catalent today welcomed the recent announcement by Phathom Pharmaceuticals that the U.S. FDA has approved both VOQUEZNA™ TRIPLE PAK™ (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets)...(PRWeb June 09, 2022)Read the full story at https://www.prweb.com/releases/catalent_supports_u_s_launch_of_phathom_pharmaceuticals_new_products_following_regulatory_approval/prweb18728261.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 9, 2022 Category: Pharmaceuticals Source Type: news

Two New Regimens Win FDA Approval for H. Pylori Infection
(MedPage Today) -- The FDA approved two vonoprazan-based regimens, one with amoxicillin and clarithromycin (Voquezna Triple Pak), and one with amoxicillin (Voquezna Dual Pak), to treat Helicobacter pylori (H. pylori) infection in adults, drugmaker... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 4, 2022 Category: American Health Source Type: news

FDA Approves Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
Voquezna Triple and Dual Paks each contain vonoprazan, a novel, first-in-class potassium-competitive acid blocker (PCAB), and have demonstrated superior eradication rates vs. lansoprazole-based triple therapy in the overall... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 4, 2022 Category: Drugs & Pharmacology Source Type: news

How Fast Does Amoxicillin Work for a UTI?
Title: How Fast Does Amoxicillin Work for a UTI?Category: Diseases and ConditionsCreated: 3/15/2021 12:00:00 AMLast Editorial Review: 3/2/2022 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - March 2, 2022 Category: OBGYN Source Type: news

amoxicillin
Title: amoxicillinCategory: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 2/2/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 2, 2022 Category: Drugs & Pharmacology Source Type: news

Widening the net: a literature review of antimicrobial agents with potential suitability for outpatient parenteral antimicrobial therapy servicesthe importance of storage and stability
Review of 18 stability studies found aminopenicillins (e.g. ampicillin and amoxicillin) appear too unstable for continuous infusion (CI). Cephalosporins vary in their stability and CI periods of 24 hours may not be achievable, and meropenem is unsuitable for CI. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 7, 2021 Category: Consumer Health News Source Type: news

Augmentin (amoxicillin/clavulanic acid, Augmentin XR, Augmentin ES-600, Amoclan)
Title: Augmentin (amoxicillin/clavulanic acid, Augmentin XR, Augmentin ES-600, Amoclan)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 12/2/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 2, 2021 Category: Drugs & Pharmacology Source Type: news

Pediatric CAP: Lower Dose, Shorter Duration Amoxicillin Effective Pediatric CAP: Lower Dose, Shorter Duration Amoxicillin Effective
For mild to moderate pediatric community-acquired pneumonia (CAP), treatment can be reduced to 3 days with low-dose twice-a-day amoxicillin.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 4, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Fluoroquinolones Linked to Sudden Death Risk on Hemodialysis Fluoroquinolones Linked to Sudden Death Risk on Hemodialysis
New data suggest an increased risk of sudden cardiac death in hemodialysis patients taking a fluoroquinolone antibiotic vs amoxicillin-based treatment, although the absolute risk is relatively small.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 22, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Amoxicillin Not Effective for Pediatric Lower Respiratory Tract Infection
Amoxicillin unlikely to be clinically effective overall or in specified clinical subgroups in whom antibiotics are commonly prescribed (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 1, 2021 Category: Respiratory Medicine Tags: Family Medicine, Infections, Nursing, Pediatrics, Pharmacy, Pulmonology, Emergency Medicine, Journal, Source Type: news

Largest trial of antibiotic amoxicillin for treating chest infections in children finds little effect
The largest randomised placebo-controlled trial of the antibiotic amoxicillin for treating chest infections in children - one of the most common acute illnesses treated in primary care in developed countries, has found it is little more effective at relieving symptoms than the use of no medication. The study, published in The Lancet and funded by the National Institute for Health Research (NIHR), was led by researchers from the University of Southampton and supported by centres at the Universities of Bristol, Oxford and Cardiff. (Source: University of Bristol news)
Source: University of Bristol news - September 28, 2021 Category: Universities & Medical Training Tags: Research, Health, International; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, Bristol Population Health Science Institute, Institutes, Eliza Source Type: news

The Case Files: Watch Out for Liver Injury in Patients Taking Amoxicillin/Clavulanic Acid
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - September 1, 2021 Category: Emergency Medicine Tags: The Case Files Source Type: news

Class 4 Medicines Defect Information, Amoxicillin 500 mg/ 5 ml Powder for oral suspension
Brown& Burk UK Limited would like to notify you of an error regarding specific batches of Amoxicillin 500 mg/ 5 ml Powder for oral suspension, sold and distributed in the UK. The product informat (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 20, 2021 Category: Drugs & Pharmacology Source Type: news